Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Hypoxic cells comprise most aggressive and therapy resistant population in the tumors therefore targeting proteins that are essential for hypoxia survival is an effective novel anti-cancer treatment. We have an ability to generate highly specific humanized synthetic antibodies against target of choice. We will generate antibodies against proteins that promote hypoxia survival, test their effect in 2D/3D systems and will move to preclinical/clinical trials upon successful in vitro validation. Partner organization will benefit from our extensive knowledge and expertise in researching hypoxia as the laboratory of Dr. Wouters is a world renowned expert in the field. I have gained a lot of experience in development and analysis of 3D cellular systems during my PhD research that concentrated in stem cell biology. Overall, this fruitful collaboration will lead to development of new line of therapeutics that could help save lives of hundreds of thousands of suffering cancer patients worldwide.
Brad Garry Wouters
Maria Kondratyev
University of Toronto
Medicine
Life sciences
University of Toronto
Elevate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.